Insider Trading disclosures for PepGen Inc

The latest disclosure was made by James McArthur in PepGen Inc where a trade of 60,719 Common Stock done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
James McArthur	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	60,719	62,413	-		0	Common Stock
James McArthur	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	271,875	271,875	-		-	Stock Option (Right to Buy)
Noel Donnelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	104,250	104,250	-		-	Stock Option (Right to Buy)
Noel Donnelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	23,283	24,956	-		0	Common Stock
Mary Beth DeLena	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	13,400	14,968	-		0	Common Stock
Mary Beth DeLena	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	60,000	60,000	-		-	Stock Option (Right to Buy)
Noel Donnelly	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 1.68 per share.	24 Feb 2025	1,527	1,673	-	1.7	2,565	Common Stock
Noel Donnelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2025	3,200	3,200	-		0	Common Stock
Mary Beth DeLena	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2025	3,000	3,000	-		0	Common Stock
Mary Beth DeLena	General Counsel	Sale of securities on an exchange or to another person at price $ 1.68 per share.	24 Feb 2025	1,432	1,568	-	1.7	2,406	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	24 Jul 2024	201	201	-	10.2	2,052	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jul 2024	7,571	50,000	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jul 2024	201	57,571	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.06 per share.	24 Jul 2024	7,571	0	-	18.1	136,741	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	24 Jul 2024	7,571	7,571	-	10.2	77,300	Common Stock
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.00 per share.	24 Jul 2024	201	0	-	18.0	3,619	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	18 Jul 2024	12,625	12,625	-	10.2	128,901	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jul 2024	12,625	57,772	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.20 per share.	18 Jul 2024	12,625	0	-	18.2	229,804	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	12 Jul 2024	3,288	3,288	-	10.2	33,570	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Jul 2024	5,901	70,397	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Jul 2024	3,288	76,298	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.00 per share.	12 Jul 2024	5,901	0	-	18.0	106,247	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	12 Jul 2024	5,901	5,901	-	10.2	60,249	Common Stock
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.04 per share.	12 Jul 2024	3,288	0	-	18.0	59,331	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.22 per share.	01 Jul 2024	37	37	-	10.2	378	Common Stock
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.01 per share.	01 Jul 2024	875	0	-	18.0	15,760	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	01 Jul 2024	875	875	-	10.2	8,934	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2024	37	79,586	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2024	875	79,623	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.08 per share.	01 Jul 2024	37	0	-	18.1	669	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2024	9,260	80,498	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.19 per share.	24 Jun 2024	9,260	0	-	18.2	168,427	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	24 Jun 2024	9,260	9,260	-	10.2	94,545	Common Stock
Laurie B. Keating	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Heidi Henson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Joshua Resnick	Director		20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Habib Joseph Dable	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Howard Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	8,667	8,667	-		-	Stock Option (Right to Buy)
Christopher Ashton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jun 2024	1,086	89,758	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jun 2024	500	90,844	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.06 per share.	11 Jun 2024	1,086	0	-	18.1	19,615	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	11 Jun 2024	500	500	-	10.2	5,105	Common Stock
Michelle L. Mellion	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	11 Jun 2024	1,086	1,086	-	10.2	11,088	Common Stock
Michelle L. Mellion	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 18.04 per share.	11 Jun 2024	500	0	-	18.0	9,022	Common Stock
Michelle L. Mellion	SVP, Clinical Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	1,411	91,344	-		-	Stock Option (Right to Buy)
Michelle L. Mellion	SVP, Clinical Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	05 Jun 2024	7,245	7,245	-	10.2	73,971	Common Stock
Michelle L. Mellion	SVP, Clinical Development	Sale of securities on an exchange or to another person at price $ 18.09 per share.	05 Jun 2024	7,245	0	-	18.1	131,062	Common Stock
Michelle L. Mellion	SVP, Clinical Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.21 per share.	05 Jun 2024	1,411	1,411	-	10.2	14,406	Common Stock

Showing 1 to 50 of 112 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

92.18% Fall from 52W High

Insider Trading disclosures for PepGen Inc

The latest disclosure was made by James McArthur in PepGen Inc where a trade of 60,719 Common Stock done was reported to US exchanges on March 3, 2025.

Screeners based on Insider Trading and SAST parameters